Gene Kinney on BioFlash Podcast

Our CEO Gene Kinney sat down with San Francisco Business Times biotech reporter Ron Leuty in April 2017 to discuss Prothena’s pipeline of novel protein immunotherapies. Gene had the opportunity discuss our past, present and future and to share how Prothena is utilizing immunotherapy to target AL amyloidosis and Parkinson’s disease. You can listen to the conversation on the BioFlash Podcast.